Crossmark

MOFs-based nanoagent enables dual mitochondrial damage in synergistic antitumor therapy via oxidative stress and calcium overload

Crossref DOI link: https://doi.org/10.1038/s41467-021-26655-4

Published Online: 2021-11-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bao, Weier

Liu, Ming

Meng, Jiaqi

Liu, Siyuan

Wang, Shuang https://orcid.org/0000-0002-9189-602X
Jia, Rongrong

Wang, Yugang https://orcid.org/0000-0001-5675-2509
Ma, Guanghui https://orcid.org/0000-0001-9154-5556
Wei, Wei https://orcid.org/0000-0002-6244-3187
Tian, Zhiyuan https://orcid.org/0000-0002-1436-6818
License Information

Text and Data Mining valid from 2021-11-04

Version of Record valid from 2021-11-04
More Information

Article History

Received: 31 March 2021

Accepted: 19 October 2021

First Online: 4 November 2021

Competing interests

: The authors declare no competing interests.